Wound care at a crossroads: precision manufacturing meets a growing global need

Published: 16-Jul-2025
Medical Devices

The wound care market is undergoing a quiet transformation. Although headlines often focus on breakthrough drugs or cutting-edge wearables, the evolution of wound dressings and their manufacture is just as significant

You need to be a subscriber to read this article.
Click here to find out more.

As the global market surges towards an estimated value of $44.2 billion by 2034, driven by factors such as rising surgical volumes, an ageing population and the diabetes epidemic, it's no longer enough to think of wound care products as simple clinical consumables.1

They're medical technologies in their own right and they’re only getting more advanced, reports Chris Locke, Chief Technology Officer at PolarSeal. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
See more

You may also like

Drug Delivery

Neuraxpharm and Dizlin to co-develop patient-centric Parkinson's drug device

Read more
The infusion belt pump delivers a levodopa-carbidopa combo to advanced Parkinson's patients who can no longer rely on oral medications

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Wound care at a crossroads: precision manufacturing meets a growing global need The wound care market is undergoing a quiet transformation. Although headlines often focus on breakthrough drugs or cutting-edge wearables, the evolution of wound dressings and their manufacture is just as significant
  2. In my view: the future of inhalation Lei Mao, Director of Inhalation Science and Product Development at Recipharm, discusses innovations in the inhaled drugs market
  3. Advances in medical technology Overhauling operating models to create digital value
  4. Neuraxpharm and Dizlin to co-develop patient-centric Parkinson's drug device The infusion belt pump delivers a levodopa-carbidopa combo to advanced Parkinson's patients who can no longer rely on oral medications
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Pre-filled syringes: trends and tips from the experts Pre-filled syringes have become a major growth market, but the delivery format does not come free of challenges or competition. Susan Birks reports on the trends and developments discussed at the recent SMi Pre-filled Syringes Conference, held in London

Upcoming event

POWTECH

23-25 September 2025 | Exhibition | Nuremberg, Germany See all

You may also like

Drug Delivery

Neuraxpharm and Dizlin to co-develop patient-centric Parkinson's drug device

The infusion belt pump delivers a levodopa-carbidopa combo to advanced Parkinson's patients who can no longer rely on oral medications
Manufacturing

Overcoming challenges associated with MedTech manufacturing: Fanuc's guide

When producing medical devices, manufacturers must primarily consider hygiene, stability and energy efficiency
Manufacturing

Gelest opens US specialty chemical manufacturing site in Pennsylvania

The Pennsylvania, US manufacturing site will provide specialty precursor chemicals to the medical device and semiconductor markets
Medical Devices

Why rigorous clinical evaluations matter: strategies to boost safety and compliance

This white paper provides a blueprint for achieving excellence in clinical evaluations through strategic enhancements
Medical Devices

At China International Medical Equipment Fair, TekniPlex Healthcare to feature robust radiation-sterilisable PVC compounds

Company also will showcase tracheal tube balloon compounds with patient-centric properties, as well as extensive PTA/PTCA balloon catheter tubing capabilities
Manufacturing

IMed Consultancy debuts whitepaper on the opportunities PMS can offer medical device manufacturers

The whitepaper details how manufacturers in the medical device space can use post market surveillance to monitor the safety of their products, while also discovering new opportunities
Drug Delivery

Kindeva Drug Delivery to supply nerve agent antidote autoinjector to the US SNS

The CDMO will produce the DuoDote autoinjecter containing atropine and pralidoxime chloride at its fill/finish manufacturing facility in St Louis, Missouri
Subscribe now